BALDUINI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 6.485
EU - Europa 4.562
AS - Asia 3.812
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 10
SA - Sud America 7
Totale 14.912
Nazione #
US - Stati Uniti d'America 6.417
CN - Cina 3.424
IE - Irlanda 1.474
UA - Ucraina 789
FI - Finlandia 656
DE - Germania 440
SE - Svezia 428
IT - Italia 325
SG - Singapore 303
GB - Regno Unito 222
FR - Francia 109
CA - Canada 64
IN - India 34
BE - Belgio 28
RU - Federazione Russa 21
IR - Iran 18
RO - Romania 18
EU - Europa 15
AU - Australia 14
NL - Olanda 14
CZ - Repubblica Ceca 11
TR - Turchia 11
MU - Mauritius 8
GR - Grecia 7
NZ - Nuova Zelanda 6
BR - Brasile 5
DK - Danimarca 4
JP - Giappone 4
PT - Portogallo 4
KZ - Kazakistan 3
AR - Argentina 2
AT - Austria 2
CH - Svizzera 2
HK - Hong Kong 2
IL - Israele 2
MX - Messico 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
ES - Italia 1
ET - Etiopia 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
KH - Cambogia 1
KR - Corea 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 14.912
Città #
Dublin 1.472
Chandler 1.361
Jacksonville 1.156
Nanjing 1.034
Ashburn 448
Boardman 440
Nanchang 419
Princeton 311
Shenyang 303
Changsha 294
Wilmington 293
Medford 291
Lawrence 289
Hebei 287
Beijing 238
Jiaxing 223
Singapore 201
Tianjin 159
Hangzhou 158
Ann Arbor 138
Helsinki 136
Shanghai 75
Milan 71
Woodbridge 70
Pavia 60
Houston 46
New York 44
Norwalk 43
Verona 42
Toronto 41
Fairfield 38
Seattle 28
Brussels 27
Los Angeles 23
Ningbo 22
Zhengzhou 21
Des Moines 20
Guangzhou 19
Jinan 19
Auburn Hills 16
Pune 16
Taizhou 14
Munich 12
Timisoara 12
Dearborn 11
Falls Church 11
Kunming 11
Rome 11
San Francisco 11
Fuzhou 10
Brno 9
Paris 9
Tappahannock 9
Washington 9
Orange 8
Palermo 8
Andover 7
Dallas 7
Melbourne 7
Redwood City 7
Ankara 6
Ardabil 6
Changchun 6
Chongqing 6
Frankfurt am Main 6
Lanzhou 6
Leawood 6
London 6
Ottawa 6
Borås 5
Chicago 5
Monmouth Junction 5
Padova 5
Bari 4
Hamilton 4
Leeds 4
Tehran 4
Turin 4
Aversa 3
Bologna 3
Fayetteville 3
Florence 3
Moscow 3
Plymouth 3
Preston 3
Sacramento 3
Santa Clara 3
St Petersburg 3
Tokyo 3
Trentola-Ducenta 3
Acapulco de Juárez 2
Aprilia 2
Belo Horizonte 2
Bratislava 2
Brescia 2
Buffalo 2
Caserta 2
Casorate Sempione 2
Clifton 2
Edmonton 2
Totale 10.725
Nome #
Antigeni minori di istocompatibilità 118
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 86
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 85
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 82
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 82
Anomalous erythrocytes produced by rabbits with liver damage. 81
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 81
Effect of platelet GP llb-llla complex occupancy on early stages of platelet activation 81
Spectrum of the mutations in Bernard-Soulier syndrome. 80
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 78
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 78
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 78
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 77
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. 76
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 76
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 75
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 74
Aggregation of human platelets stimulates calcium ion movement and release reaction. 74
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. 73
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 73
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 73
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 72
A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) IB and severely reduced amounts of GPIX and GPV. 71
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly). Clinical and laboratory findings. 71
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 71
Autoimmunità e piastrinopatie [Autoimmunity and platelet disorders] 71
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin. 71
Spontaneous long-lasting remission in a young patient with angioimmunoblastic lymphadenopathy with dysproteinemia. 71
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 71
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 70
Confronto di due metodi di criopreservazione piastrinica basati sull'impiego di glicerolo-glucosio o DMSO: studio della funzionalità piastrinica in vitro. 70
[Idiopathic myelodysplastic syndromes. A caseload contribution]. 70
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 70
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 70
A Leu40Pro substitution in the leucine rich motif (LRM) of glycoprotein (GP) IX is responsible for dysfunction of a normally expressed GPIB alpha in Bernard-Soulier syndrome (BSS) 70
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 70
Osteomalacia ipofosfatemica secondaria ad emangiopericitoma sottocutaneo. Studio clinico ed istopatologico di un caso. 69
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 69
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 69
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 69
MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype. 68
Autologous transfusion of thrombosol plus low-dose DMSO cryopreserved platelet concentrates (PCs) for severe thrombocytopenia following high-dose chemotherapy (HDC). 67
Autologous cryopreserved platelets can efficiently support patients with breast cancer after high-dose chemotherapy and circulating progenitor cell transplantation 67
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 67
Lessons in platelet production from inherited thrombocytopenias. 66
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 66
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 65
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. 64
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. 64
Splenectomia in corso di porpora trombocitopenica idiopatica: fattori prognostici e risultati clinici. 64
Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells. 64
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 64
Acute granulocytic leukemia with Alder-Reilly inclusions. 64
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 64
THE D1424N AND R1933X MUTATIONS OF MYH9 CAUSE THROMBOCYTOPENIA THROUGH LOSS OF REGULATION OF PROPLATELET FORMATION BY TYPE I COLLAGEN. 64
Inherited thrombocytopenias: from genes to therapy. 63
Thrombopoietin levels in patients with primary and reactive thrombocytosis. 63
Platelet composition and function in patients undergoing cardiopulmonary bypass for hearth surgery. 63
Effect of 52 monoclonal antibodies against platelet membrane on platelet aggregation and release reaction 63
Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines. 63
Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. 63
Transfusion of platelet concentrates cryopreserved with thromboSol plus low-dose dimethilsulphoxide in patients with severe thrombocytopenia: a pilot study 62
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 62
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 62
A modified technique for therapeutic leukapheresis using a discontinuous flow. 62
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 62
Glycopeptides of erythrocyte membranes in some hematological disorders 62
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 62
Desmopressin and platelets: In vitro and in vivo studies 62
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 62
In vitro and in vivo effects of desmopressin on platelet function 62
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 62
3D silk bone marrow model: a promising tool to test efficacy of new biomimetic drugs on platelet production 62
Platelet count and aging 61
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 61
Acquired immune thrombastenia: a new bleeding disorder. 61
Malattia di von Willebrand tipo IIb: descrizione di un caso clinico 61
Inherited thrombocytopenias. The evolving spectrum. 61
Platelet predeposit and transfusion in patients receiving high-dose chemotherapy and autologous transplant for breast cancer 61
May-Hegglin anomaly: Clinical and laboratory investigation of 14 cases 61
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 61
Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine 61
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 61
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 61
Possible evolution of human parvovirus B19 infection into erythroleukemia 60
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 60
Haemophagocytic syndrome responding to high-dose gamma-globulin as presenting feature of sarcoidosis. 60
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 60
Incompatibility at CD31, HPA3 or HPA5 loci are HLA-A2-restricted risk factors for acute GVHD. 60
The Case. Proteinuria and low platelet count. 60
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. 60
Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation. 60
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 60
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation. 59
Expression, activation, and subcellular localization of the Rap1 GTPase in cord blood-derived human megakaryocytes. 59
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives. 59
Ristocetin-induced platelet agglutination stimulates GPIIb-IIIa-dependent calcium influx. 59
Structure and"in vitro"function of platelets stored as platelet concentrates at room temperature. 59
International prognostic scoring system (IPSS) and other prognostic systems for myelodysplastic syndromes (MDS). 59
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 59
Totale 6.740
Categoria #
all - tutte 66.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020844 0 0 0 0 0 166 59 164 20 317 112 6
2020/20211.625 171 138 53 148 8 223 10 265 86 257 211 55
2021/20221.399 25 0 47 24 51 51 25 82 70 47 182 795
2022/20234.032 452 242 25 354 398 434 7 209 1.706 24 99 82
2023/20241.250 168 212 42 130 124 334 23 89 9 50 49 20
2024/2025800 76 337 92 115 56 124 0 0 0 0 0 0
Totale 15.510